Banner Granted Approval for Amantadine Softgel Capsules
Posted on: Tuesday, 3 June 2008, 12:00 CDT
Banner Pharmacaps has received the FDA approval for its abbreviated new drug application for Amantadine Hydrochloride USP 100mg soft gelatin capsules.
Amantadine is indicated for the prophylaxis and treatment of signs and symptoms of infection in the respiratory tract caused by various strains of influenza A virus.
Amantadine is also utilized in the treatment of Parkinson's disease and drug-induced extrapyramidal reactions.
Source: Datamonitor
Related Articles
- Old Drug May Become New Bird Flu Weapon
- Reserve Antivirals for Pandemic Use
- CDC: Flu Resists 2 Antiviral Drugs -- Don't Use Rimantadine, Amantadine, Feds Warn
- Officials Warn Against Using 2 Ineffective Flu Drugs
- Hong Kong Medic Allays Concerns on Flu-Resistant Drugs
- CDC Announces Change in Recommendations for Use of Antivirals; Clinicians Should Not Prescribe Two Common Antivirals
- Amantadine curbs weight gain with psychiatric drug
- Drug Resistant Bird Flu in Southeast Asia
- Drug Resistant Avian Influenza Viruses More Common in Southeast Asia than North America
Rating: 3.1 / 5 (8 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds